James C. Hamilton, Insider at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 50,786 shares at $35.00 ($1.8M) on 2024-01-05, disclosed to the SEC on 2024-01-05.
Scheduled sale ($1.8M) by Insider under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.81 | 3,500 | $111K | 6.3% |
| 2 | $32.52 | 2,300 | $75K | 4.2% |
| 3 | $33.30 | 500 | $17K | 0.9% |
| 4 | $34.00 | 1,800 | $61K | 3.5% |
| 5 | $34.94 | 8,000 | $280K | 15.8% |
| 6 | $35.00 | 10,000 |
| $350K |
| 19.7% |
| 7 | $35.65 | 12,343 | $440K | 24.8% |
| 8 | $35.65 | 12,343 | $440K | 24.8% |
| Total | $34.92 avg | 50,786 | $1.8M | 100% |
| Filing → |
| ARWR | SELL | 2026-01-05 | $2.5M | — | Filing → |
| ARWR | SELL | 2025-10-03 | $700K | — | Filing → |
| ARWR | SELL | 2025-09-16 | $450K | — | Filing → |